Scientists are engineering immune cells to find and kill tumor cells. Geisel immunologist Charles Sentman, PhD, and colleagues from across Dartmouth are developing CAR T-cell therapies that can potentially treat nearly 80-90% of human tumors, as explained in this video. Read more about Dartmouth’s CAR T-cells.
Learn more about Immunotherapy Innovation and Entrepreneurship at Dartmouth.
